Research Publications


The HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 haplotype protects autoantibody-positive relatives from type 1 diabetes throughout the stages of disease progression

Pugliese, A; Boulware, D; Yu, L; Babu, S; Steck, AK; Becker, D; Rodriguez, H; DiMeglio, L; Evans-Molina, C; Harrison, LC; Schatz, D; Palmer, JP; Greenbaum, C; Eisenbarth, GS; Sosenko, JM; Type 1 Diabetes TrialNet Study, Group
Journal Article in press
The HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 haplotype is linked to protection from development of type 1 diabetes (T1D). However, it is not known at which stages in the natural history of T1D development this haplotype affords protection. We examined a cohort of 3,358 autoantibody-positive relatives of T1D patients in the Pathway to Prevention (PTP) Study of the Type 1 Diabetes TrialNet. The PTP study examines risk factors for T1D and disease progression in relatives. HLA-typing revealed that 155 relatives carried this protective haplotype. A comparison with 60 autoantibody-negative relatives suggested protection from autoantibody development. Moreover, the relatives with HLA-DRB1*15:01-DQA1*01:02-DQB1*06:02 less frequently expressed autoantibodies associated with higher T1D risk, were less likely to have multiple autoantibodies at baseline, and rarely converted from single to multiple autoantibody positivity on follow-up. These relatives also had lower frequencies of metabolic abnormalities at baseline, and exhibited no overall metabolic worsening on follow-up. Ultimately, they had a very low 5-year cumulative incidence of T1D. In conclusion, the protective influence of the DRB1*15:01-DQA1*01:02-DQB1*06:02 haplotype spans from autoantibody development through all stages of progression, and relatives with this allele only rarely develop T1D.
American Diabetes Association
Population Health and Immunity
Refer to copyright notice on published article.

Creation Date 2016-03-14 03:05:31 Last Modified 2016-03-14 03:48:06